CTRI/2021/03/031665尚未招募4 期
Efficacy and Safety of Ivermectin prophylaxis for Covid-19 Infection in Health care Personnel: A Randomized Controlled Clinical Trial
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Health care personnel (HCP) >18 years age
- •2.HCP identified as primary contact and have High Risk defined as per ICMR guidelines for contracting COVID-19 infection
- •3.HCP who have not presented with general symptoms such as general discomfort, fever, cough, dyspnoea or muscle pain in the last week.
- •4.HCP who are willing to give written informed consent
排除标准
- •1.Already infected with SARS-cov-2/ previous COVID-19 within the last 6 months
- •2.HCW who have taken any medication as possible prophylaxis for COVID-19
- •3.Pregnancy
- •4.Prior enrolment into this or other COVID-19 prevention or treatment trials.
- •5.HCW with known allergy to ivermectin
研究者
相似试验
已完成
3 期
Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patientsCOVID-19.COVID-19, virus identifiedU07.1IRCT20200408046987N3Akam Tejarat Fartak Farasoo Company800
已完成
2 期
Evaluating the effect of Ivermectin on covid 19 patientsCOVID 19.Corona virus infection, unspecifiedU07.1IRCT20200404046937N4Ahvaz University of Medical Sciences60
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49
招募中
3 期
Ivermectin in Prevention and Treatment of COVID-19TCTR20210929002Faculty of Medicine Siriraj Hospital, Mahidol university1,000
招募中
2 期
Effect of ivermectin in COVID-19IRCT20200329046892N3Rasht University of Medical Sciences60